| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |